Combination Chemotherapy With Irinotecan and Cisplatin for Large-Cell Neuroendocrine Carcinoma of the Lung: A Multicenter Phase II Study

Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e31828f6989
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Phase II Study of Docetaxel and Irinotecan Combination Chemotherapy in Metastatic Gastric Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2006English

Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/Ii Clinical Study

Oncologist
Cancer ResearchMedicineOncology
2016English

Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

Anticancer Research
MedicineCancer ResearchOncology
2020English

Combined Large Cell Neuroendocrine Carcinoma of the Lung

Journal of Cell Science & Therapy
2015English

Large Cell Neuroendocrine Carcinoma of the Lung: A 10-Year Clinicopathologic Retrospective Study

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2004English

Fractionated Administration of Irinotecan and Cisplatin for Treatment of Lung Cancer: A Phase I Study

British Journal of Cancer
Cancer ResearchOncology
1999English

Phase II Study of Docetaxel Alternating With Cisplatin in Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer

Anti-Cancer Drugs
Cancer ResearchOncologyPharmacology
2000English

The Demographic and Treatment Options for Patients With Large Cell Neuroendocrine Carcinoma of the Lung

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Randomized Phase III Trial of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients With Extensive-Disease Small Cell Lung Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy